VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1651831
Sex: F
Age:
State: NC

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Patient received the second dose of vaccine on 17Mar2021; Have not had a period since receiving the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Mar2021 at 09:00 (at the age of 44-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 17Mar2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication from an unknown date and unknown if ongoing. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received the second dose outside the range of 19-42 days after the first dose and hence there was a medication error (inappropriate scheduling of vaccine administered). On 03Mar2021 at 09:00, the patient has not had a period since receiving the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event not had a period since receiving the vaccine was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO

Current Illness:

ID: 1651832
Sex: F
Age:
State: NJ

Vax Date: 04/27/2021
Onset Date: 05/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: "Black and blue'; Muscles spasms; "my neck ,legs, i feel pangs and my head"; "my neck ,legs, I feel pangs"; "my neck ,legs, I feel pangs"; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 27Apr2021 at 10:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS).Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 RNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 03May2021, the patient reported black and blue and her neck, legs, she felt pangs and her head and muscles spasms. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "black and blue" and "neck, legs, she felt pangs and her head" and muscles spasms were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651833
Sex: F
Age:
State: NY

Vax Date: 01/04/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: 4 months after receiving a Pfizer vaccine, developed without signifiant PMHx developed shingles.; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration in the left arm on 04Jan2021 at 16:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 12:00, 4 months after receiving a Pfizer vaccine, the patient without significant past medical history (PMHx) developed shingles. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with Valacyclovir 1g PO TID x 10days. The clinical outcome of the event shingles was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651834
Sex: F
Age:
State: TX

Vax Date: 05/08/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Small, itchy, pink bump at the second injection site; Small, itchy, pink bump at the second injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 08May2021 at 11:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included Birth control tablets and multivitamin tablets from on an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 17Apr2021 at 15:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:45, the patient experienced small, itchy, pink bump at the injection site that appeared seven days after. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event small, itchy, pink bump at the injection site was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651835
Sex: F
Age:
State: FL

Vax Date: 04/29/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: I have hereditary lymphedema in my legs which became much worse/swelling/inner side of the knee where it was very swollen; I have hereditary lymphedema in my legs which became much worse; Having very sharp nerve pain; Stinging burning pain which is extremely sensitive to touch/Burning pain/ stinging burning pain was also behind her knee; Stinging burning pain which is extremely sensitive to touch/Burning pain; I also had a sore swollen lymph node; I also had a sore swollen lymph node; A broken blood vessel in my right eye; This is a spontaneous report from a contactable consumer via COVAES. This non-pregnant 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0171) via an unspecified route of administration in the left arm on 29Apr2021 (at 64-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, peripheral neuropathy, and hereditary lymphedema, all from unknown dates and unknown if ongoing. The patient had no allergies, had not received any other vaccines within 4 weeks prior to the COVID vaccine, and had not been diagnosed with COVID-19 prior to vaccination. Concomitant medications included gabapentin, baclofen, bupropion, and cetirizine, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EW0151) in the left arm on 07Apr2021 (at the age of 64-years-old) for COVID-19 immunisation. The patient reported on 03May2021, she had hereditary lymphedema in her legs which became much worse within one week following the 2nd shot; further stating it had never been that bad before. The swelling was so severe that she believed it was pressing on nerves because she was having very sharp nerve pain and stinging burning pain which was extremely sensitive to touch. The stinging burning pain was also behind her knee and on the inner side of the knee where it is very swollen. She also had multiple sclerosis so at first she thought it was just from that because at the same time she had burning pain in her left side too and no lymphedema there. She reported that whenever she got sick with a virus it exacerbated her multiple sclerosis and burning pain was one of the symptoms. She also had a sore swollen lymph node under her left arm and a broken blood vessel in her right eye, which she had never had before, 2 days after the second shot. The patient reported that a doctor's office visit was required for the events, and that no treatment was received for the events. The clinical outcomes of the events were not recovered.

Other Meds: GABAPENTIN; BACLOFEN; BUPROPION; CETIRIZINE

Current Illness:

ID: 1651836
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Puking; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0179) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0175) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient had experienced puking and chills on an unknown date. The clinical outcome of the events puking and chills was unknown at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1651837
Sex: M
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 21Apr2021 at 14:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient had no known allergies to food, medicine or other products. The patient did not receive any other medications within two weeks prior to vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 the patient experienced pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651838
Sex: M
Age:
State: TX

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:101.2 (unspecified units); Comments: approximately 1pm fever of 101.2

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; approximately 1pm fever of 101.2; approximately 12pm fatigue and body aches; approximately 12pm fatigue and body aches; Morning after approximately 9am sore arm and headache,; Morning after approximately 9am sore arm and headache,; approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; This is a spontaneous report from a contactable consumer, patient. A 15-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in a left arm on 14May2021 at 17:00(at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety and depression. The patient did not have known allergies to food, medication or other product. The patient did not receive any medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15May2021 approximately at 09:00 the patient experienced sore arm and headache in the morning, on the same day approximately at 12:00 experienced fatigue and body aches, approximately at 13:00 experienced fever of 101.2 and approximately at 14:00 patient experienced vomiting, body aches fatigue headache and nausea continued throughout the day. The event did not result in doctor or other healthcare professional office/clinic visit. On 15May2021 the patient checked body temperature and resulted 101.2 (unspecified units). Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headache, fatigue, body ache, fever, vomiting and nausea were recovering, at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651839
Sex: F
Age:
State: AZ

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Diarrhea, occurred the day after receiving 1st vaccine, in the morning. Also had it again after eating dinner two or three times.; Then proceeded to vomit once; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 14May2021 at 12:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. The patient did not receive concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15May2021 at 08:00 the patient experienced diarrhea, occurred the day after receiving 1st vaccine, in the morning. Also had it again after eating dinner two or three times. Then vomited once. Do not know how long it was last. Patient had a hope it will resolve itself tomorrow. Elisa is 12 years old had received vaccine within a few days of vaccinations opening to her age group. Therapeutic measures were not taken as a result of the reported event(s). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event diarrhea, occurred the day after receiving 1st vaccine, in the morning and then vomit once was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651840
Sex: M
Age:
State: VA

Vax Date: 05/11/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Extreme dizziness; Nausea; Vomiting lasting for multiple days and still has not gone away.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 11May2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not allergic to any medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 20Apr2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021, at 12:00, the patient had extreme dizziness, nausea and vomiting lasting for multiple days and still has not gone away. It was reported that the patient would try to see a physician the following day. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events dizziness, nausea and vomiting were unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651841
Sex: M
Age:
State: IL

Vax Date: 04/21/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Lymph nodes still swollen to this day,; twitching of leg, upper lip; headaches after consumption of alchocol that were not bad at all prior to injection; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0172) via an unspecified route of administration in the left arm on 21Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Apr2021, the patient experienced lymph nodes still swollen to this day, twitching of leg, upper lip and headaches after consumption of alcohol that were not bad at all prior to injection. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event lymph nodes still swollen to this day, twitching of leg, upper lip and headaches after consumption of alcohol that were not bad at all prior to injection were unknown at the time of this report. No follow-up attempts are needed. No further information is expected. .

Other Meds:

Current Illness:

ID: 1651842
Sex: F
Age:
State: OK

Vax Date: 05/09/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Pain in arm; tiredness; Headaches; Congestion; Mood swings; Extreme fatigue; Upset stomach; Running nose; Sore throat; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09May2021 at 11:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, allergy to nuts and nickel. Concomitant medications included zolpidem tartrate (AMBIEN), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and valaciclovir hydrochloride (VALTREX), all for unknown indication and from unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, the patient experienced pain in arm and quick onset tiredness which lasted for few days. On day 4, the patient experienced running nose, sore throat, fever, body aches and from day 5-7, patient experienced headaches, body aches, congestion, fever, sore throat, mood swings, extreme fatigue, upset stomach. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events pain in arm, tiredness, running nose, sore throat, body aches, headache, congestion, fever, mood swings, extreme fatigue and upset stomach was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: AMBIEN; ADDERALL; VALTREX

Current Illness:

ID: 1651843
Sex: M
Age:
State: OR

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202105; Test Name: MAP test; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Comments: Nasal Swab; covid_test_result=Pending

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Lump on Left Armpit; Lump on Left Armpit that is tender and hurts. Suspect to be Lymphnode; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 13May2021 at 14:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL) for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Apr2021 at 15:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 14May2021 at 10:15, the patient experienced a lump on the left armpit that was tender and hurt and was suspected to be a lymph node. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. The patient had been tested for COVID post-vaccination. On an unknown date in May2021, the patient underwent nasal swab test named MAP test and the result was pending. The clinical outcome of the events lump on the left armpit and armpit was tender were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1651844
Sex: F
Age:
State: NJ

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: Chest X-ray; Result Unstructured Data: Test Result:a small amount of fluid in my left lung; Test Date: 2021; Test Name: Chest CT; Result Unstructured Data: Test Result:clear; Test Date: 2021; Test Name: EKG; Result Unstructured Data: Test Result:unknown results; Test Date: 2021; Test Name: nasal scope; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Had to cough/this dry, unproductive cough has continued; A small amount of fluid in my left lung; This is a spontaneous report from a contactable consumer (patient). This 59-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 12Apr2021 at 17:30 (at the age of 59-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high cholesterol and acid reflux. The patient had not been sick with an illness over the last year and a half (as of 16May2021). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included rosuvastatin (CRESTOR; 5 mg) and omeprazole (PRILOSEC) from unknown dates for unknown indications. The patient did not have any known allergies. The patient previously received dose 1 of BNT162B2 on 22Mar2021 at 17:30 as a single dose in the left arm for COVID-19 immunization. On 13Apr2021 at 07:30 the patient experienced a dry, unproductive cough. The event was reported as non-serious. The patient was not hospitalized for the event. The patient visited an ear, nose, throat (ENT) doctor and primary/cardiologist doctor as a result of the event. The morning after the second vaccine (13Apr2021) the patient woke up and immediately upon taking a deep breath had to cough. This sensation continued for approximately half the day after which she could take a deep breath without coughing but she continued to intermittently have the sensation to cough. This dry, unproductive cough continued for the last 4 and a half weeks (as of 16May2021). Other than the cough she had no other symptoms that would indicate illness. The patient underwent lab tests and procedures which included nasal scope by her ENT doctor on an unknown date with unknown results, blood work on an unknown date with unknown results, EKG on an unknown date with unknown results, chest X-ray on an unknown date with results of small amount of fluid in her left lung, and chest CT on an unknown date which was clear. The ENT and cardiologist felt this was some sort of reaction to the vaccine. The patient did not receive any treatment for the events. The outcomes of dry, unproductive cough, and fluid in her left lung were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.

Other Meds: CRESTOR; PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1651845
Sex: F
Age:
State: TN

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: extreme fatigue; cramping for a couple of days; diarrhea; early period that's been much heavier and longerthan usual; early period that's been much heavier and longerthan usual; early period that's been much heavier and longerthan usual; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 11May2021 at 14:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food or other products. Concomitant medications included ethinylestradiol, norethisterone acetate (MICROGESTIN) and escitalopram oxalate (ESCITALOPRAM). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced extreme fatigue along with cramping for a couple of days, diarrhoea then an early period that's been much heavier and longer than usual. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme fatigue, cramping for a couple of days, diarrhoea, early period that's been much heavier and longer were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: MICROGESTIN; ESCITALOPRAM

Current Illness:

ID: 1651846
Sex: M
Age:
State: MA

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210514; Test Name: Body temperature; Result Unstructured Data: Test Result:100.7 Units:[degF]; Comments: Fever 100.7F for 24 hours

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: felt like I had lost body mass and I was flat as cardboard.; felt like an elephant was sitting on me; vivid, bizarre dreams; interrupted sleep; Sinking feeling at times; Feeling of having full blown viral infection; could not sleep well at all due to crazy body ache; could not sleep well at all due to crazy body ache; Fever 100.7F; massive fatigue; Every muscle ached; joint pain all over; persistent headache; shoulder pain; Neck pain; Distended Stomach; This is a spontaneous report from a contactable healthcare professional. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 14May2021 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraines and the patient was allergic to penicillin and sulfa drugs. Concomitant medications included regular multivitamins (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. The patient previously took ciprofloxacin and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 21:30, the patient experienced fever 100.7 degrees Fahrenheit for 24 hours and massive fatigue, every muscle ached, joint pain all over, persistent headache, shoulder and neck pain, distended stomach. On 14May2021, the first night, he could not sleep well at all due to crazy body ache. On 15May2021, as the fever subsided, the patient felt like he had lost body mass and he was flat as card board, also felt like an elephant was sitting on him for 36 hours. On 15May2021, the second night, the patient had very vivid, bizarre dreams, interrupted sleep and the same dreams continued after falling back to sleep, the patient felt sinking at times and felt of having full blown viral infection. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measure was taken for fever and included treatment with tylenol. The clinical outcome of the events fever and felt like an elephant was sitting were resolved on 15May2021 and 16May2021 respectively, while the clinical outcome of the events massive fatigue, every muscle ached, joint pain all over, persistent headache, shoulder and neck pain, distended stomach, crazy body ache, lost body mass, vivid, bizarre dreams, interrupted sleep, felt sinking at times and felt of having full blown viral infection were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651847
Sex: M
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: COVID-19 test; Test Result: Negative

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Altered taste; Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0179, expiration date: 31Aug2021), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date, the patient experienced altered taste and headache after a week and still going on. Patient did a COVID-19 test on an unspecified date and result was negative. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. The clinical outcome of the events altered taste and headache was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651848
Sex: F
Age:
State: IN

Vax Date: 05/08/2021
Onset Date: 05/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: strick pain though out the day above each side of hips, maybe kidney or ovaries; lower back pain goingup the spine; lower back pain; severe headaches; strick pain though out the day above each side of hips, maybe kidney or ovaries; pain in arm; chest pain; night sweat; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 08May2021 at 00:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09May2021 at 00:00, on the day 1, the patient experienced pain in arm, chest pain and night sweat. On 10May2021, on the day 2, the patient experienced strick pain though out the day above each side of hips, maybe kidney or ovaries. On 12May2021, on the day 4, the patient experienced lower back pain and severe headaches. On 16May2021, on the day 8, the patient experienced continue lower back pain going up the spine. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events pain in arm, chest pain and night sweat, strick pain though out the day above each side of hips, maybe kidney or ovaries, lower back pain and severe headaches and continue lower back pain going up the spine were not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651849
Sex: M
Age:
State: KY

Vax Date: 03/01/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Tinnitus since first dose, similar to feel I have after driving long distances; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on an unknown date in Mar2021 at 09:00 (at the age of 51-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 22Apr2021 at 09:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high uric acid and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced tinnitus since first dose which was similar what patient experienced after driving long distances. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event tinnitus since first dose which was similar to the patient had after driving long distances was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651850
Sex: F
Age:
State: MD

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: cough; wheezing; Major congestion; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the arm left on 13May2021 at 08:15(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included colecalciferol (manufacturer-VITAMIN D3), cyanocobalamin (manufacturer-VITAMIN B12), calcium (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN)and glucose (manufacturer-GLUCOS) and multivitamin all taken from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021 at 08:00 the patient experienced Major congestion(Nasal congestion), cough and wheezing. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event Major congestion(nasal congestion) cough and wheezing were not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; CALCIUM; BUPROPION; GLUCOS

Current Illness:

ID: 1651851
Sex: F
Age:
State: PA

Vax Date: 04/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: has a fever; This is a spontaneous report from a contactable consumer (parent) reporting for her daughter (patient). A female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 23Apr2021 as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history were not reported. On an unspecified date in 2021, patient experienced fever. Patient was scheduled for second dose on 14May2021, and her parent (reporter) wanted to know if she could postpone the appointment. Outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651852
Sex: M
Age:
State: MA

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Headache; Fatigue; Swollen knee joint; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0183) via an unspecified route of administration in the left arm on 10May2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL). Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 13:00, the patient experienced headache, fatigue and swollen knee joint. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events headache and fatigue were recovered on an unknown date in May2021. The clinical outcome of the event swollen knee joint was not recovered (as of 6 days later as reported) at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SIMVASTATIN; LISINOPRIL; TYLENOL

Current Illness:

ID: 1651853
Sex: F
Age:
State: NC

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Pain at injection site; Back pain; Extreme fatigue; Runny nose; Sore throat; This is a spontaneous report from a contactable healthcare professional, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14May2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, hypothyroidism and depression. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication was unknown if ongoing. Previously, the patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Apr2021 at 14:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. It was reported that the patient had no allergies to medications, food, or other products. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15May2021 at 14:00, the patient experienced pain at the injection site, back pain, extreme fatigue, runny nose, sore throat. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain at the injection site, back pain, extreme fatigue, runny nose, sore throat was recovering at the time of the report. No follow-up attempts are needed; information about the lot number cannot be obtained.

Other Meds: LEVOTHYROXINE; BUPROPION; ESCITALOPRAM

Current Illness:

ID: 1651854
Sex: F
Age:
State: PA

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Body aches; Immediately on injection arm burned from shoulder to elbow; Headache; Dizzy started late that night; Foggy started late that night; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the right arm on 15May2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 in Feb2021, the patient reported that due to COVID-19 she experienced loss of taste, loss of smell and long-term fatigue. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Concomitant medications included an intrauterine device- levonorgestrel (MIRENA) for an unknown indication form an unknown date. On 15May2021 at 14:00, the patient reported that her arm burned from shoulder to elbow immediately on injection. On 15May2021, the patient experienced headache and dizzy/foggy which started late that night. On 16May2021 at 07:15, the patient woke up from body aches and had to keep "stretching" like she had a fever but none was present. The patient reported that these events experienced after the vaccination felt similar to the events, she previously experienced when she had COVID-19. The patient hoped that after she got the vaccine, it would bring back her taste and smell and help with the long-term fatigue. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of events headache and body aches and included treatment with ibuprofen which the patient took around midnight on 15Apr2021. The patient reported that she took ibuprofen and TYLENOL every 3 hours alternating. The clinical outcome of the events immediately on injection arm burned from shoulder to elbow, headache, dizzy/foggy and body aches was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MIRENA

Current Illness:

ID: 1651855
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: stabbing pain in the opposite arm where shot was administered. The pain was in the upper arm in the same vacinity but on the other arm, a month later started to get stabbing pain in that same left arm, same location, and it is very painful; difficult to move and do things; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the right arm on 15Apr2021 at 12:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other medications in two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 at 12:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Initially within a few days of the second shot, the patient experienced stabbing pain in the opposite arm where shot was administered and the pain was in the upper arm in the same vacinity but on the other arm and had no other side effects and the pain went away in a few days. On 15May2021 at 20:00, now a month later, the patient experienced to get stabbing pain in that same left arm, same location, and it was very painful and difficult to move and do things and had a very high tolerance for pain but the fact that this was surfacing over a month later and with more pain than before was concerning. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events stabbing pain in the opposite arm where shot was administered and the pain was in the upper arm in the same vacinity but on the other arm and had no other side effects and the pain went away in a few days. Now, a month later, started to get stabbing pain in that same left arm, same location, and it was very painful and was difficult to move and do things and had a very high tolerance for pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651856
Sex: F
Age:
State: OH

Vax Date: 05/09/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210514; Test Name: COVID-19 test; Result Unstructured Data: Test Result:COVID-19 negative; Comments: They did a covid test, it was negative.

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: vomitting; cold; Diarrhea; I began experiencing symptoms of flu,; congestion; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0185) via an unspecified route of administration in the left arm on 09May2021 at 16:00(at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, pre-diabetic and insect bite allergy. Concomitant medications included pharmacy. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11May2021, after two days of vaccination, the patient experienced symptoms of flu, congestion and headache. On 14May2021 after five days, experienced strong headache and went to seek urgent care, they did a COVID-19 test and it was negative. On day seventh day, on 16May2021, the symptoms continued like vomiting, cold, diarrhea and severe headache. The patient went to urgent care again and got a check-up and was provided with an antibiotic. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken which included antibiotics for the reported events. On 14May2021, patient underwent a COVID-19 test and the result was negative. The clinical outcome of the events symptoms of flu, congestion, headache, vomiting, cold, and diarrhea was not recovered, at the time of this report. No follow-up attempts are possible; No further information is expected.

Other Meds:

Current Illness:

ID: 1651857
Sex: F
Age:
State: OH

Vax Date: 05/03/2021
Onset Date: 05/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09May2021 at 15:00, the patient experienced shingles. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with shingle cream, Valacyclovir and Tylenol. The clinical outcome of the event shingles was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651858
Sex: F
Age:
State: IN

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: little itchy bumps in left hand; little itchy bumps in left hand; finger was swollen and itchy; big red itch splotch; injection site is incredibly huge swollen and very red; injection site is incredibly huge swollen and very red; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 13May2021 at 16:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none that the patient knows of. Known allergies were reported as none that the patient knows of. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021, the day after the patient got the shot, the patient started to get little itchy bumps in her left hand. The patient didn't think anything of it. On Saturday (as reported) the patient had to take off her wedding ring because her finger was swollen and itchy. The patient had a big red itch splotch on her ring finger with a few itchy bumps on her left hand and also her injection site was incredibly huge swollen and very red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events little itchy bumps in left hand, finger was swollen and itchy, big red itch splotch, injection site incredibly huge swollen and very red were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651859
Sex: F
Age:
State: IL

Vax Date: 03/12/2021
Onset Date: 03/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: My cycle, which is routinely 21-26 days has been 37 and 42 days.; Flow is also much heavier/ My periods are always 3 days. The last two have been 6 and 8 (and counting).; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, seasonal allergy, hypertension. The patient had no known allergies. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT), cetirizine hydrochloride (ZYRTEC), fluticasone propionate; salmeterol xinafoate (ADVAIR), multivitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 00:00, the patient experienced periods had been affected by each dose. Her cycle which was routinely 21-26 days had been 37 and 42 days. periods were always 3 days. The last two have been 6 and 8 (and counting). The flow was also much heavier and the side effects more intense. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events cycle which was routinely 21-26 days had been 37 and 42 days, periods were always 3 days, the last two have been 6 and 8 (and counting), the flow was also much heavier and the side effects more intense was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SINGULAIR; ZOLOFT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ADVAIR

Current Illness:

ID: 1651860
Sex: F
Age:
State: WA

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Severe joint pain in both knees; Painful to bend and straighten legs; Soreness in vaccination location; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 12May2021 at 13:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included prediabetes, depression, graves' disease, dermatitis herpetiformis. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), and vitamin d nos (VITAMIN D) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the right arm on 21Apr2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 12:00, the patient experienced severe joint pain in both knees starting the day after second shot. Same type of pain, same location. Painful to bend and straighten legs. Lasted for 3 days. Almost gone on fourth day. No other joint or muscle pain, other than soreness in injection location. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events severe joint pain in both knees, Painful to bend and straighten legs, soreness in injection location was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; SERTRALINE; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1651861
Sex: F
Age:
State: TX

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Bad rash all over body; Dizziness; weakness; Jaw pain; Ear pain; Severe pain at injection site; Tiredness; Muscle pain; Chills; Joint pain; Fever; Injection site swelling; injection site redness; nausea; Feeling unwell; Swollen lymph nodes under right arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 14May2021 at 13:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient not had any allergies to medication, food or any other products. Concomitant medications included zinc (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D) for unknown indications from unknown start dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 22Apr2021 at 13:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 21:00 the patient experienced bad rash all over body, dizziness, weakness, jaw pain, ear pain, severe pain at injection site, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling and redness, nausea, feeling unwell, swollen lymph nodes under right arm. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events of bad rash all over body, dizziness, weakness, jaw pain, ear pain, severe pain at injection site, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling and redness, nausea, feeling unwell, swollen lymph nodes under right arm were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZINC; VITAMIN D NOS

Current Illness:

ID: 1651862
Sex: M
Age:
State: NJ

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: The subject received his first shot at scheduled time from a female staff. During his 15 minutes observation period, another male staff gave him a second full dose shot by accident.; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) in the arm left on 15May2021 at 14:15 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medications. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 14:30, the patient had received first shot at scheduled time from a female staff. During the fifteen minutes observation period, another male staff gave a second full dose shot by accident. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of this event. The clinical outcome of the event medication error occurred as another male staff gave him a second full dose shot by accident was unknown at this time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651863
Sex: F
Age:
State: VA

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210516; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Tiredness; Headache; Chills; 100.5 fever; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 15May2021 at 15:45 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 07:00 the patient experienced tiredness, headache, chills and 100.5 fever. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events tiredness, headache, chills and 100.5 fever was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651864
Sex: M
Age:
State: OH

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Balance off; Tiredness; Having trouble moving/Having trouble getting up and down; Sore arm at injection site; Having trouble speaking(Slurring words); Forgetfulness; Mushy brain; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in Arm Left on 13May2021 14:15 at age of 68-year-old (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included diabetic, chronic heart disease, chronic kidney failure, blood clot in lung. Known allergies included warfin. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Apr2021 04:45 PM, at age of 68-year-old in Right arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN); bumetanide (BUMEX); gabapentine (GABAPENTINE). The patient experienced balance off, tiredness, having trouble moving/having trouble getting up and down, sore arm at injection site, having trouble speaking(Slurring words), forgetfulness, mushy brain on 14May2021 with outcome of not recovered. No treatment was received, the events were reported as non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; BUMEX; GABAPENTINE

Current Illness:

ID: 1651865
Sex: M
Age:
State: KY

Vax Date: 04/16/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20200918; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 18Sep2020, the patient underwent nasal swab test for COVID-19 and the result was negative. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included unspecified treatment. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651866
Sex: F
Age:
State: FL

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: pressure in chest; no appetite (no hungry); huge headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14May2021 at 17:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:00, the patient experienced huge headache. Therapeutic measures were taken as a result of the event and included treatment with TYLENOL. On 16May2021, the patient experienced pressure in chest, have no appetite (no hungry). The patient did not receive any treatment for the events. The clinical outcome of events huge headache, pressure in chest, have no appetite (no hungry) was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1651867
Sex: F
Age:
State: CA

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Soreness, bruising at injection site; Soreness, bruising at injection site; dry+ scratchy throat with nasal congestion; dry+ scratchy throat with nasal congestion; dry+ scratchy throat with nasal congestion; Dose 1: 20210501 and Dose2: 20210515; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 12:30, (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia, oral allergy syndrome and allergy to penicillin. Concomitant medications included cetirizine hydrochloride (ZYRTEC), for unknown indication from an unknown date. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 at 14:30, (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021, the patient experienced Soreness, bruising at injection site, and dry + scratchy throat with nasal The patient did not receive any treatment for the reported event. The clinical outcome of the event vaccination site pain, vaccination site bruising, dry throat, itchy throat and nasal congestion was recovered on 16May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1651868
Sex: M
Age:
State: CA

Vax Date: 05/12/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Itching; Red around upper chest; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0183) via an unspecified route of administration in the arm left on 12May2021 at 14:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications included lisinopril dihydrate (LISINOPRIL) for unknown indication. The patient reported that he was taking medication for high blood pressure which was unspecified. The patient previously took compazine (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 10:00, the patient experienced itching and red around upper chest. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event itching and red around upper chest was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL

Current Illness:

ID: 1651869
Sex: M
Age:
State: MO

Vax Date: 05/14/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Bloody nose with long clothes removed loud of nose; Headache; Feeling of a concussion; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 14May2021 at 09:30 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD. The patient did not have any allergies to medications, food or other products. Concomitant medication included methylphenidate hydrochloride (CONCERTA) from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 23Apr2021 at 13:15 (at the age of 25-years-old), as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 14:45, the patient experienced bloody nose with long clothes removed loud of nose, headache, feeling of a concussion. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events bloody nose with long clothes removed loud of nose, headache and feeling of a concussion were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CONCERTA

Current Illness:

ID: 1651870
Sex: F
Age:
State: MO

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Right arm aches where the shot was given, some days worse than others.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 20Apr2021 at 10:45 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included colecalciferol (VIT.D3), ascorbic acid (VITAMIN C) and vitamin b complex (B-COMPLEX); all from unknown dates for unspecified indications. The patient previously received TAMIFLU and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 30Mar2021 at 10:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines with in four weeks of the COVID-19 vaccination. On 20Apr2021 at 13:00, the patient experienced "right arm aches where the shot was given, some days worse than others." The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event "right arm aches where the shot was given, some days worse than others." was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VIT D3; VITAMIN C [ASCORBIC ACID]; B COMPLEX [VITAMIN B COMPLEX]

Current Illness:

ID: 1651871
Sex: F
Age:
State: TN

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Dizziness; disorientation; body aches; switching between feeling too hot and too cold; headache; nausea; arm pain; extreme tiredness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 15May2021 at 16:30 hours (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) 20 mg, daily and testosterone phenylpropionate (TESTOSTERONE) 25 mg, weekly, both from unknown date for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 24Apr2021 at 16:30 hours (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15May2021 at 21:00 hours the patient experienced dizziness, disorientation, body aches, switching between feeling too hot and too cold, headache, nausea and extreme tiredness. No therapeutic measures were taken a s a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event dizziness, disorientation, body aches, switching between feeling too hot and too cold, headache, nausea, pain and extreme tiredness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; TESTOSTERONE

Current Illness:

ID: 1651872
Sex: F
Age:
State: VA

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210515; Test Name: Body Temperature; Result Unstructured Data: Test Result:101 Units:{DF}; Comments: fever of 101 (units unspecified)

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Headache; fever of 101; Chills; Strange dreams; Insomnia; several bowel movements; hemorrhoids; Fatigue; all over body pain; Dizziness; tightness in chest; Difficulty breathing; muscle pain in injected arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 15May2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), baclofen (MANUFACTURER UNKNOWN), zolpidem tartrate (AMBIEN), omeprazole (MANUFACTURER UNKNOWN) and ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 24Apr2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 14:30, the patient experienced headache, fever of 101, chills, strange dreams, insomnia, several bowel movements which caused haemorrhoids, fatigue, all over body pain, dizziness, fatigue, tightness in chest, difficulty breathing and muscle pain in injected arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, fever of 101, chills, strange dreams, insomnia, several bowel movements, hemorrhoids, fatigue, all over body pain, dizziness, tightness in chest, difficulty breathing and muscle pain in injected arm were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN; BACLOFEN; AMBIEN; OMEPRAZOLE; LO LOESTRIN FE

Current Illness:

ID: 1651873
Sex: M
Age:
State: NC

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210516; Test Name: Heart Rate; Result Unstructured Data: Test Result:41-47 (units not specified); Comments: Detected on Apple Watch Series 6, happened 10min after injection

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Blurry Vision; Irregular heartbeats; Low heart rate "41-47"; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0176) via an unspecified route of administration in the left arm on 16May2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, asthma and penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 11:10, the patient experienced irregular heartbeats, Low heart rate "41-47" detected on apple watch series 6, this happened 10min after injection and subsided about 1hour later. On16May2021 at 17:30, the patient experienced blurry vision. She was fasting for 18hours at time of injection, but drinking plenty of water. Therapeutic measures were taken as a result of AE(s) and included treatment with cold compress and a bottle of water. The clinical outcome of the event irregular heartbeats, low heart rate "41-47" was recovered on 16May2021 at 12:10. The clinical outcome of the event blurry vision was unknown at time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651874
Sex: M
Age:
State: CT

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Soreness in the arm that received the vaccination; This is a spontaneous report from a contactable consumer. A 12-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0185) via intramuscular route of administration in the left arm on 16May2021 at 09:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to Lactose intolerance. Concomitant medication included tilactase (LACTAID) from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16May2021 at 17:00, the patient experienced soreness in the arm that received the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of soreness in the arm that received the vaccination was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LACTAID

Current Illness:

ID: 1651875
Sex: M
Age:
State: PA

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210516; Test Name: PCR; Result Unstructured Data: Test Result:Pending; Test Date: 20210516; Test Name: Rapid Antigen; Test Result: Negative

Allergies:

Symptom List: Vomiting

Symptoms: Fatigue; Congestion; Headache; Low grade fever; Sore throat; Anatomical location at left leg; This is a spontaneous report from a contactable consumer, the parent. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0168) via an unspecified route of administration in the leg left on 15May2021 at 09:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and penicillin allergy. Concomitant medications included cyanocobalamin (B12) on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The vaccine was administered in the left leg hence there was a medication error (vaccine administered at the inappropriate site). On 15May2021 at 15:00 the patient experienced fatigue, congestion, headache, low grade fever and sore throat. On 16May2021, the patient underwent rapid antigen test for COVID-19 virus and the result was found to be negative. On 16May2021, the patient underwent PCR test for COVID-19 and the result was pending. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events fatigue, congestion, headache, low grade fever and sore throat were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: B12 [CYANOCOBALAMIN]

Current Illness:

ID: 1651876
Sex: M
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:Goes up and down between 98 and 100(unspecified...; Comments: Goes up and down between 98 and 100(unspecified units) Constantly changing temperature (goes up and down between 98 and 100)

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Constantly changing temperature (goes up and down between 98 and 100); Weird issues with my hearing; Flared up temporomandibular joint; Elevated heart rate; Elevated blood pressure (usually at 120. Now it was at 138); Inflamed muscles; Body aches; Weight loss - despite trying to eat a lot more to compensate for it.; Bowel issues; Taste buds altered. I don't taste pineapples and other fruits correctly; Weakness; Fatigue; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 04May2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient took doxycycline on an unknown date for unknown indication and experienced drug allergy. Concomitant medications included ALLEGRA, montelukast (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 21Apr2021 at 11:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 18:00, the patient experienced constantly changing temperature (goes up and down between 98 and 100), fatigue, weird issues with hearing, flared up temporomandibular joint (TMJ) that has not been present for years, elevated heart rate, elevated blood pressure (usually at 120. It was at 138 at the time of report), these are still going on, 2 weeks after the shot, inflamed muscles, body aches, weakness, weight loss - despite trying to eat a lot more to compensate for it, bowel issues and taste buds altered. The patient don not taste pineapples and other fruits correctly. The adverse events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events constantly changing temperature (goes up and down between 98 and 100), fatigue, weird issues with hearing, flared up temporomandibular joint (TMJ), elevated heart rate, elevated blood pressure (usually at 120. It was at 138 at the time of report), inflamed muscles, body aches, weakness, weight loss, bowel issues and taste buds altered were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; MONTELUKAST; OMEPRAZOLE

Current Illness:

ID: 1651877
Sex: M
Age:
State: NY

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 05/16/2021; Test Name: Body temperature; Result Unstructured Data: Test Result: 100.6?F.

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0164), at the age of 60, via an unspecified route of administration, left arm, on May 15, 2021, at 16:00, single dose, for COVID-19 immunisation. Medical history included no other health issues. The patient does not have any allergies to food, medications or other products. Patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot#EW0158), at the age of 60, via an unspecified route of administration, left arm, on Apr 24, 2021, at 16:00, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On May 16, 2021, at 10:00, patient experienced temperature of 100.6?F, chills, weakness, muscle pain, some muscle failure, nausea, vomiting and shortness of breath. No therapeutic measures taken as a result of the events. On May 16, 2021, patient underwent lab tests, which include body temperature and the result was 100.6?F. The outcome of 100.6?F, chills, weakness, muscle pain, some muscle failure, nausea, vomiting and shortness of breath: not recovered (at the time of report). No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1651878
Sex: F
Age:
State: IN

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Metrorrhagia 24 hours post vaccine.; Period was not due for at least one more week.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 14May2021 at 08:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, COVID-19 and allergy to gluten. The patient did not take any concomitant medication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 23Apr2021 at 08:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:15, 24 hours post vaccine the patient experienced metrorrhagia and Period was not due for at least one more week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event metrorrhagia and irregular periods was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651879
Sex: M
Age:
State: TX

Vax Date: 05/01/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20201020; Test Name: COVID test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: series of rashes across back, shoulders, and buttocks; constantly itch; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169), via an unspecified route of administration in the left arm on 01May2021 at 08:45 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history was not available and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729), via an unspecified route of administration in the left arm on 09Apr2021 at 08:45 (at the age of 36-year-old), as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had been tested for COVID-19. On 05May2021, patient experienced series of rashes across back, shoulders, and buttocks and constantly itch for a couple of hours and then go away and start again the next day. On 20Oct2020, the patient underwent lab tests and procedures which included COVID test (Nasal swab) and the result was negative. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event series of rashes across my back, shoulders, and buttocks and constantly itch was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651880
Sex: F
Age:
State:

Vax Date: 05/11/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fever; headache; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer (reported for her daughter). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 11May2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in May2021, the patient experienced fever and headache. Therapeutic measures were taken as a result of events included treatment with Tylenol. The second dose was scheduled on 01Jun2021. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am